Will a Glaucoma Drug Revolutionize Androgenetic Alopecia Treatment? On Repurposing a Drug Whose Side Effect Became a Desired Therapy Outcome.

    November 2024 in “ Postępy Biochemii
    Kalina Spławska, Łukasz Zybaczyński, Maciej Wierzbicki, Katarzyna Koziak
    Image of study
    TLDR Latanoprost may be a promising new treatment for hair loss.
    The article discusses the potential of latanoprost, a synthetic analog of prostaglandin F2α originally used to treat glaucoma, as a treatment for androgenetic alopecia. Latanoprost's side effect of excessive eyelash growth has led to interest in its active metabolite, latanoprost acid, as a promising alternative to minoxidil and finasteride, the only currently registered treatments for this type of hair loss. The development of hair loss treatments containing prostaglandin derivatives, including latanoprost acid, is expected to be faster than traditional drug development processes.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 105 results

      community New Latanoprost-Based Formula Used by Hollywood Celebrities

      in Treatment  26 upvotes 1 year ago
      A new Latanoprost-based formula used by Hollywood celebrities to treat hair loss, with the formula containing minoxidil, tretinoin, melatonin, azelaic acid, zinc thymulin, vitamin B6, sandalore and methyl vanillate. It also mentions the potential of offering a combined sublingual minoxidil/oral dutasteride option in the future.

      community Growth Stimulants that aren't Minoxidil...?

      in Research/Science  7 upvotes 7 months ago
      The user is exploring hair growth stimulants other than Minoxidil, mentioning Stemoxydine, various peptides, drugs like Latanoprost and Bimatoprost, and natural remedies such as Rosemary Oil and Caffeine. They express concerns about the long-term effectiveness and safety of these alternatives and seek more information on viable options for hair regrowth.

      community All Drugs in Clinical Trials in 2023

      in Research/Science  69 upvotes 1 year ago
      12 companies having drugs or therapies in clinical trials during 2023, with various molecules and phases of trial; the probability that some may fail; and progress being made in the field.

    Similar Research

    5 / 388 results